Trial Outcomes & Findings for Effect of tDCS Timing on Safety Memory in PTSD (NCT NCT04152772)

NCT ID: NCT04152772

Last Updated: 2025-10-21

Results Overview

Main protocol: Threat reactivity as quantified by skin conductance responses to a conditioned and subsequently extinguished stimulus versus a never conditioned stimulus.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

62 participants

Primary outcome timeframe

Study visit day 4: during administration of fear extinction memory.

Results posted on

2025-10-21

Participant Flow

Participant milestones

Participant milestones
Measure
Active Then Sham Transcranial Direct Current Stimulation
Participants received 2mA transcranial direct current stimulation (tDCS) during extinction learning of conditioned threat, followed by sham tDCS for the same duration
Sham Then Active Transcranial Direct Current Stimulation
Participants received sham transcranial direct current stimulation (tDCS) during extinction learning of conditioned threat, followed by active, 2mA tDCS
Sham Then Sham Transcranial Direct Current Stimulation
Participants received sham transcranial direct current stimulation (tDCS) during extinction learning of conditioned threat, followed by sham tDCS
Overall Study
STARTED
19
20
23
Overall Study
COMPLETED
19
20
22
Overall Study
NOT COMPLETED
0
0
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

One participant did not disclose their age

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Active Then Sham Transcranial Direct Current Stimulation
n=19 Participants
Participants received 2mA transcranial direct current stimulation (tDCS) during extinction learning of conditioned threat, followed by sham tDCS for the same duration
Sham Then Active Transcranial Direct Current Stimulation
n=20 Participants
Participants received sham transcranial direct current stimulation (tDCS) during extinction learning of conditioned threat, followed by active, 2mA tDCS
Sham Then Sham Transcranial Direct Current Stimulation
n=23 Participants
Participants received sham transcranial direct current stimulation (tDCS) during extinction learning of conditioned threat, followed by sham tDCS
Total
n=62 Participants
Total of all reporting groups
Age, Continuous
45.2 years
STANDARD_DEVIATION 14.7 • n=19 Participants • One participant did not disclose their age
46.9 years
STANDARD_DEVIATION 15.5 • n=19 Participants • One participant did not disclose their age
43.7 years
STANDARD_DEVIATION 16.6 • n=23 Participants • One participant did not disclose their age
45.2 years
STANDARD_DEVIATION 15.5 • n=61 Participants • One participant did not disclose their age
Sex: Female, Male
Female
15 Participants
n=19 Participants
13 Participants
n=20 Participants
21 Participants
n=23 Participants
49 Participants
n=62 Participants
Sex: Female, Male
Male
4 Participants
n=19 Participants
7 Participants
n=20 Participants
2 Participants
n=23 Participants
13 Participants
n=62 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=19 Participants
0 Participants
n=20 Participants
3 Participants
n=23 Participants
3 Participants
n=62 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
19 Participants
n=19 Participants
20 Participants
n=20 Participants
20 Participants
n=23 Participants
59 Participants
n=62 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=19 Participants
0 Participants
n=20 Participants
0 Participants
n=23 Participants
0 Participants
n=62 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=19 Participants
0 Participants
n=20 Participants
0 Participants
n=23 Participants
0 Participants
n=62 Participants
Race (NIH/OMB)
Asian
0 Participants
n=19 Participants
1 Participants
n=20 Participants
1 Participants
n=23 Participants
2 Participants
n=62 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=19 Participants
0 Participants
n=20 Participants
1 Participants
n=23 Participants
2 Participants
n=62 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=19 Participants
0 Participants
n=20 Participants
0 Participants
n=23 Participants
1 Participants
n=62 Participants
Race (NIH/OMB)
White
17 Participants
n=19 Participants
19 Participants
n=20 Participants
18 Participants
n=23 Participants
54 Participants
n=62 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=19 Participants
0 Participants
n=20 Participants
3 Participants
n=23 Participants
3 Participants
n=62 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=19 Participants
0 Participants
n=20 Participants
0 Participants
n=23 Participants
0 Participants
n=62 Participants
Posttraumatic Stress Disorder (PTSD) Checklist for DSM-5
48.00 Average score on the PCL-5
STANDARD_DEVIATION 12.34 • n=19 Participants
44.80 Average score on the PCL-5
STANDARD_DEVIATION 14.48 • n=20 Participants
41.98 Average score on the PCL-5
STANDARD_DEVIATION 15.52 • n=23 Participants
44.73 Average score on the PCL-5
STANDARD_DEVIATION 14.26 • n=62 Participants

PRIMARY outcome

Timeframe: Study visit day 4: during administration of fear extinction memory.

Main protocol: Threat reactivity as quantified by skin conductance responses to a conditioned and subsequently extinguished stimulus versus a never conditioned stimulus.

Outcome measures

Outcome measures
Measure
Active tDCS During Extinction Learning Followed by Sham tDCS During Consolidation
n=19 Participants
Participants received 2mA transcranial direct current stimulation (tDCS) during extinction learning of conditioned threat, followed by sham tDCS for the same duration
Sham tDCS During Extinction Followed by Active tDCS During Consolidation
n=19 Participants
Participants received sham transcranial direct current stimulation (tDCS) during extinction learning of conditioned threat, followed by active, 2mA tDCS
Sham tDCS During Extinction Followed by Sham tDCS During Consolidation
n=21 Participants
Participants received sham transcranial direct current stimulation (tDCS) during extinction learning of conditioned threat, followed by sham tDCS
Skin Conductance Responses
0.075 Skin conductance in microsiemens
Standard Error 0.025
0.088 Skin conductance in microsiemens
Standard Error 0.026
0.057 Skin conductance in microsiemens
Standard Error 0.025

Adverse Events

Group 1: Active tDCS During Extinction Learning and Sham tDCS During Consolidation

Serious events: 0 serious events
Other events: 16 other events
Deaths: 0 deaths

Group 2: Sham tDCS During Extinction Learning and Active tDCS During Consolidation

Serious events: 0 serious events
Other events: 18 other events
Deaths: 0 deaths

Group 3: Sham tDCS During Extinction Learning and Sham tDCS During Consolidation

Serious events: 0 serious events
Other events: 19 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Group 1: Active tDCS During Extinction Learning and Sham tDCS During Consolidation
n=19 participants at risk
In group 1 active tDCS was applied during the extinction learning phase followed by sham tDCS during the consolidation phase. Transcranial direct current stimulation included 15 minutes of 2 mA intensity.
Group 2: Sham tDCS During Extinction Learning and Active tDCS During Consolidation
n=20 participants at risk
In group 2 sham tDCS was applied during the extinction learning phase followed by active tDCS during the consolidation phase. Transcranial direct current stimulation included 15 minutes of 2 mA intensity.
Group 3: Sham tDCS During Extinction Learning and Sham tDCS During Consolidation
n=23 participants at risk
In group 3 sham tDCS was applied during the extinction learning phase followed by sham tDCS during the consolidation phase. No transcranial direct current stimulation was applied.
Nervous system disorders
Headache
0.00%
0/19 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
5.0%
1/20 • Number of events 1 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
8.7%
2/23 • Number of events 2 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
Skin and subcutaneous tissue disorders
Neck or scalp pain
0.00%
0/19 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
5.0%
1/20 • Number of events 1 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
4.3%
1/23 • Number of events 1 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
Nervous system disorders
Ringing or buzzing in ears
0.00%
0/19 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
0.00%
0/20 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
0.00%
0/23 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
Psychiatric disorders
Acute mood change
15.8%
3/19 • Number of events 3 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
10.0%
2/20 • Number of events 2 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
30.4%
7/23 • Number of events 7 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
Nervous system disorders
Difficulty concentrating
5.3%
1/19 • Number of events 1 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
10.0%
2/20 • Number of events 2 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
8.7%
2/23 • Number of events 2 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
Nervous system disorders
Feeling sleepy or drowsy
47.4%
9/19 • Number of events 9 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
60.0%
12/20 • Number of events 12 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
39.1%
9/23 • Number of events 9 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
Nervous system disorders
Experience of flickering lights
26.3%
5/19 • Number of events 5 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
5.0%
1/20 • Number of events 1 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
4.3%
1/23 • Number of events 1 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
Nervous system disorders
Feeling dizzy or lightheaded
0.00%
0/19 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
5.0%
1/20 • Number of events 1 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
4.3%
1/23 • Number of events 1 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
Gastrointestinal disorders
Feeling nauseous
0.00%
0/19 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
0.00%
0/20 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
0.00%
0/23 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
Skin and subcutaneous tissue disorders
Skin sensations/redness
68.4%
13/19 • Number of events 13 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
85.0%
17/20 • Number of events 17 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.
69.6%
16/23 • Number of events 16 • One day, following active tDCS or sham stimulation
A transcranial direct current stimulation side effects questionnaire was used following active tDCS or sham stimulation.

Additional Information

Mascha van 't Wout-Frank

Butler Hospital

Phone: 401-680-4198

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place